MTP Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

MTP Therapeutics General Information

Description

Developer of anti-cancer drugs designed for the treatment of solid tumors. The company specializes in the development of a peptide antagonist of neuropilin that is capable of inhibiting the proliferation of tumor cells, migration, and angiogenesis, enabling clinicians to provide better treatment for cancerous tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Strasbourg
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Strasbourg
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MTP Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Aug-2023 Completed Startup
2. Accelerator/Incubator 01-Jan-2013 Completed Startup
1. Grant 27-Sep-2011 $69.2K Completed Startup
To view MTP Therapeutics’s complete valuation and funding history, request access »

MTP Therapeutics FAQs

  • Where is MTP Therapeutics headquartered?

    MTP Therapeutics is headquartered in Strasbourg, France.

  • What industry is MTP Therapeutics in?

    MTP Therapeutics’s primary industry is Drug Discovery.

  • Is MTP Therapeutics a private or public company?

    MTP Therapeutics is a Private company.

  • What is MTP Therapeutics’s current revenue?

    The current revenue for MTP Therapeutics is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process